BiopharmIQ
Catalyst Calendar
Big Movers™
All Big Movers™
Current Qtr Report
PDUFA Events
PDUFA Calendar
Current PDUFA Report
Company Screener
M&A Activity
Historical M&A Data
M&A Target Ideas
Meeting Calendar
Hedge Funds
Analysts & Portfolios

My WatchlistsMy Notes
Try Pro FreeAlready have an account? Login

Enterprise Value

78.76M

Cash

24.22M

Avg Qtr Burn

-5.71M

Short % of Float

4.88%

Insider Ownership

2.88%

Institutional Own.

13.07%

Qtr Updated

03/31/23


Drug Pipeline

Powered by

Only showing assets and stage. See catalyst data with a free or premium account. Unlock more data with a free account.

Drug & IndicationStage & EventCatalyst Date
HEPZATO KIT (melphalan hydrochloride for injection/hepatic delivery system) Details
Liver Dominant metastatic Ocular Melanoma

Big Mover™

Suspected Mover™

Susp. Mover™

PDUFA

Approval decision

Some catalyst date

You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details.Sign up now.
CHEMOSAT® Details
Uveal melanoma

Phase 2

Data readout

Some catalyst date

You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details.Sign up now.
HEPZATO KIT (melphalan hydrochloride for injection/hepatic delivery system) Details
Intrahepatic cholangiocarcinoma

Failed

Discontinued

Some catalyst date

You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details.Sign up now.